American Century Companies
CAI

American Century Companies’s Caris Life Sciences CAI Stock Holding History

American Century Companies’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$267K Buy
+14,940
New +$327K ﹤0.01% 2658
2025
Q4 		– Sell
-6,865
Closed -$208K – 2901
2025
Q3 		$208K Buy
+6,865
New +$219K ﹤0.01% 2692

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies's CAI Position: Q1 2026 in Review

American Century Companies opened a new position in Caris Life Sciences (CAI) in Q1 2026: 14,940 shares worth $267K. The stake represents ﹤0.01% of the portfolio and ranks #2658 among its holdings. This is a return to the name: American Century Companies previously reported a position in CAI as recently as Q3 2025.

American Century Companies first reported a position in CAI in Q3 2025 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • American Century Companies held 14,940 shares of Caris Life Sciences worth $267K as of Q1 2026.
  • Caris Life Sciences was a new American Century Companies position in Q1 2026.
  • Caris Life Sciences made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2658 holding.
  • American Century Companies first reported a position in Caris Life Sciences in Q3 2025 and has held it in 2 quarters since.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.